Neonatal Hyperbilirubinemia and Jaundice —

Hyperbilirubinemia is the most common condition requiring medical attention in newborns, affecting roughly 60% of term and 80% of preterm infants. Understanding the difference between benign physiologic jaundice and dangerous pathologic jaundice — and recognizing the early signs of kernicterus — is essential for safe newborn nursing care.

Definition

Hyperbilirubinemia is an elevated level of bilirubin in the blood.
It causes jaundice, a yellow discoloration of the skin and sclera.
Affects approximately 60% of term infants and 80% of preterm infants.

Bilirubin Metabolism

Bilirubin is produced from the breakdown of red blood cells; hemoglobin is converted to unconjugated (indirect) bilirubin.
Unconjugated bilirubin is fat-soluble, binds to albumin in the blood, and cannot be excreted in urine or stool.
Conjugated (direct) bilirubin is water-soluble, produced in the liver, and excreted in urine and stool.
The newborn liver is immature and cannot conjugate bilirubin efficiently, leading to accumulation of unconjugated bilirubin.

Types of Jaundice

Type	Onset	Cause	Key Points
Physiologic	After 24 hours	Immature liver; increased RBC breakdown	Peaks at 3–5 days; resolves by 7–10 days
Pathologic	Within first 24 hours	Hemolytic disease, sepsis, biliary atresia	Requires evaluation and treatment
Breastfeeding jaundice	2–4 days	Inadequate milk intake; dehydration	Treat with increased feeding frequency
Breast milk jaundice	5–7 days	Substances in breast milk inhibit conjugation	Resolves over weeks to months

Physiologic jaundice is normal and benign; appears after 24 hours and resolves without treatment.
Pathologic jaundice appears within the first 24 hours and requires workup for hemolytic disease, sepsis, or biliary atresia.
Breastfeeding jaundice is treated by increasing feeding frequency.
Breast milk jaundice generally does not require treatment.

Risk Factors

Prematurity — immature liver function and decreased bowel motility.
Hemolytic disease (ABO or Rh incompatibility) — increases bilirubin production, leading to early and severe jaundice.
Infants of diabetic mothers — polycythemia and increased RBC breakdown.
Bruising or cephalohematoma — blood breakdown releases bilirubin.
Delayed feeding — decreased bowel motility allows bilirubin reabsorption from the intestines.
Family history of jaundice — may indicate inherited conditions such as G6PD deficiency.

Signs and Symptoms

Jaundice progresses in a cephalocaudal direction — face first, then trunk and extremities.
Yellow discoloration becomes visible when bilirubin levels exceed 5 mg/dL; sclera and mucous membranes show color first.
Poor feeding and lethargy are early signs of worsening jaundice and require immediate evaluation.
Kernicterus (bilirubin-induced brain damage) presents with lethargy, poor feeding, high-pitched cry, seizures, and opisthotonos.

Diagnosis and Monitoring

Transcutaneous bilirubin — non-invasive screening tool.
Serum bilirubin — gold standard; measures total and direct bilirubin.
Direct bilirubin >1 mg/dL indicates biliary obstruction or liver disease.

Bilirubin thresholds by age

Age	Low-Risk Infant	High-Risk Infant
24 hours	<8 mg/dL	<6 mg/dL
48 hours	<13 mg/dL	<10 mg/dL
72 hours	<15 mg/dL	<12 mg/dL
96 hours	<17 mg/dL	<14 mg/dL

Treatment

Phototherapy is the most common treatment. Blue light (450–460 nm) converts unconjugated bilirubin to water-soluble isomers that can be excreted.
Intensive phototherapy (double lights or a bili blanket) is used for high bilirubin levels.
Exchange transfusion is indicated when phototherapy fails; it removes bilirubin and antibody-coated red blood cells.
Hydration is essential — increased insensible water loss during phototherapy may require additional fluids.
Continue feeding during phototherapy; breastfeeding is encouraged, and supplementation may be needed.

Complications

Kernicterus causes irreversible neurologic injury.
Signs include lethargy, poor feeding, high-pitched cry, seizures, and opisthotonos.
Long-term complications: hearing loss, cerebral palsy, and neurodevelopmental delay.
Prevention through early identification and treatment is key.

Nursing Interventions

Monitor bilirubin levels according to protocol.
Assess for jaundice every 8 hours and document progression.
Encourage feeding every 2–3 hours to promote bowel movements and bilirubin excretion.
Assess hydration during phototherapy; monitor intake and output.
Protect the eyes during phototherapy with eye patches.
Monitor temperature during phototherapy to prevent hyperthermia.
Explain treatment to parents and encourage bonding.

High-Yield Exam Traps

Do not dismiss jaundice in the first 24 hours — this is pathologic.
Do not use phototherapy without eye protection.
Do not stop breastfeeding during phototherapy.
Do not ignore signs of kernicterus.
Remember that jaundice progresses cephalocaudally.
Do not assume physiologic jaundice is always benign without monitoring.
Do not delay treatment for hyperbilirubinemia.
Direct bilirubin elevation indicates biliary obstruction.

Key takeaways

Jaundice within the first 24 hours is pathologic and always requires evaluation.
The newborn liver is immature, so unconjugated bilirubin accumulates and is the form that crosses the blood–brain barrier.
Phototherapy with eye protection and adequate hydration is the cornerstone of treatment; continue feeding throughout.
Kernicterus (lethargy, high-pitched cry, opisthotonos, seizures) causes irreversible brain injury — recognize and treat early.
A direct bilirubin >1 mg/dL points to biliary obstruction or liver disease, not simple physiologic jaundice.
Feed every 2–3 hours to promote stooling and bilirubin excretion.